Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, ...

Prenatal blood test sometimes hints at cancer in moms-to-be: study - ...

Despite a decline in cost-related medication non-adherence among asthma patients, financial hardship continues to impact one ...

Expansion Brings New Principal Investigators, Expanded Site Resources, and Accelerated Trial Initiation to Support Breakthrough Blood Cancer Therapies With the significant growth in new hematological ...

Study aims to measure impact of technology usage on youth mental health outcomes BOSTON, Dec. 10, 2024 /PRNewswire/ -- Aura, the leading all-in-one online safety solution for individuals and families, ...

Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted immuno-oncology, announced today that the US ...

ConTIPI Medical, an innovator in providing non-surgical and disposable solutions for women with various pelvic floor dysfunctions, and EVERSANA, a leading provider of global commercial services to the ...

Vital Data Technology, a leading provider of AI-driven health data analytics and medical management solutions for health plans, announced an agreement with Mid-State Health Network ...

Weiming Li, of Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has presented the latest clinical data of its novel drug candidate, olverembatinib (HQP1351) ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which shows that its Nu.Q® Cancer Test differentiated ...

(NASDAQ: IINN, IINNW), ("Inspira Technologies" or the "Company"), a groundbreaking life support technology company, revealed the expansion of its HYLA blood sensor technology ("HYLA") into an ...

("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data from the TakeAim ...